Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ConvaTec ( (GB:CTEC) ) has shared an announcement.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,640,217 of its ordinary shares through UBS AG London Branch. This move is part of a broader $300 million share buyback initiative announced earlier in August 2025. The shares were acquired at prices ranging from 236.00 to 237.40 pence and will be held in treasury. This transaction increases ConvaTec’s treasury shares to 79,898,531, while the total shares in issue stand at 1,969,891,028. The buyback is expected to enhance shareholder value and reflects the company’s confidence in its financial health.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, characterized by consistent revenue growth and solid profitability. Technical analysis indicates a moderate upward trend, although valuation metrics suggest the stock may be overvalued. The absence of earnings call insights and corporate events limits additional context.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products and technologies industry, focusing on advanced wound care, ostomy care, continence and critical care, and infusion care. The company is dedicated to improving the lives of people with chronic conditions and is a significant player in the healthcare market.
Average Trading Volume: 7,114,842
Technical Sentiment Signal: Buy
Current Market Cap: £4.63B
Find detailed analytics on CTEC stock on TipRanks’ Stock Analysis page.